RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1.
Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
食管胃腺癌(OAC)是预后不良的肥胖相关癌症,可能受益于基于自然杀伤(NK)细胞的免疫疗法。细胞免疫疗法在OAC中取得成功面临两个关键挑战,即NK细胞优先募集至网膜等肿瘤外组织而非肿瘤,以及免疫抑制性肿瘤微环境(TME)可削弱NK细胞功能。在此,我们研究了克服肥胖对NK细胞及基于NK细胞的免疫疗法不利影响的策略。我们在离体免疫细胞迁移模型中证明,NK细胞优先向OAC患者来源的网膜趋化信号迁移,而非向肿瘤迁移。我们确定了CX3CR1调节和/或肿瘤趋化因子谱重塑作为使NK细胞迁移偏向肿瘤的途径。我们还报道了肥胖OAC TME中可靶向的免疫抑制因素,这些因素削弱NK细胞功能,尤其是细胞毒性能力。这些数据为治疗性克服肥胖带来的关键挑战提供了见解,并将为OAC的基于NK细胞的免疫疗法的优越设计提供依据。
Oesophagogastric adenocarcinomas (OAC) are poor prognosis, obesity-associated cancers which may benefit from natural killer (NK) cell-based immunotherapies. Cellular immunotherapies encounter two key challenges to their success in OAC, namely recruitment to extratumoural tissues such as the omentum at the expense of the tumour and an immunosuppressive tumour microenvironment (TME) which can hamper NK cell function.
Herein, we examined approaches to overcome the detrimental impact of obesity on NK cells and NK cell-based immunotherapies.
We have demonstrated that NK cells migrate preferentially to the chemotactic signals of OAC patient-derived omentum over tumour in an ex vivo model of immune cell migration.
We have identified CX3CR1 modulation and/or tumour chemokine profile remodelling as approaches to skew NK cell migration towards tumour.
We also report targetable immunosuppressive facets of the obese OAC TME which dampen NK cell function, in particular cytotoxic capabilities. These data provide insights into approaches to therapeutically overcome key challenges presented by obesity and will inform superior design of NK cell-based immunotherapies for OAC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。